Across TCGA pan-cancer cohorts, SNORD3P1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of SNORD3P1’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where SNORD3P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNORD3P1 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

BRCA, PRAD, and KIRC are the cancer types where SNORD3P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNORD3P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.055	.010	4	view →
PRAD	All	All	+0.089	.032	2	view →
KIRC	Male	All	−0.046	.013	1	view →
LUSC	All	All	+0.045	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: SNORD3P1 RNA expression & survival · all SNORD3P1 data types